Researchers led by Osaka University's Masaki Mori looked into whether miR-146a, a microRNA suspected to be a tumor suppressor in pancreatic, breast, and prostate cancers, also has a role in gastric cancer. The researchers used qPCR to determine the levels of miR-146a present in 90 gastric cancer samples and whether those levels were associated with pathology or prognosis. Additionally, the researchers examined how miR-146a regulates EGFR and IRAK.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.